Concetta Tuccillo

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Journal: Translational oncology

Published: October 14, 2025

Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

Journal: Oncotarget

Published: August 29, 2025

Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood.

Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood.

Journal: The journal of liquid biopsy

Published: May 31, 2025

Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

Journal: International journal of molecular sciences

Published: May 29, 2025

Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells.

Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: March 24, 2025

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients.

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients.

Journal: Cell death & disease

Published: December 04, 2024

Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.

Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: October 22, 2024

DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer.

DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer.

Journal: iScience

Published: August 20, 2024

Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.

Journal: Cancers

Published: July 08, 2024

Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer.

Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer.

Journal: Journal of translational medicine

Published: June 12, 2024

PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.

PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.

Journal: Biomedicines

Published: February 29, 2024

ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC.

ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC.

Journal: Scientific reports

Published: August 08, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026